Skip to main content

Guyer William's Form 4 filing

Corcept Therapeutics Inc (CORT) · filed Apr 2, 2025

Accession no.
0000950170-25-049800
Filed
Apr 2, 2025
Trade date
Apr 1, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $77.6K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Guyer WilliamCIK 0001879013Officer (Chief Development Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 1, 2025Common StockMOption exerciseAcquired+678$21.65+$14,678.76,165Direct
Apr 1, 2025Common StockSSaleDisposed−678$114.51F2−$77,637.785,487Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 1, 2025Common StockMOption exerciseDisposed−678$0.00$0449,322Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.29 to $114.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Referenced by the price of 1 transaction in Table I.

Remarks

The power of attorney under which this form was signed is on file with the Commission.

Read the full filing on SEC EDGAR (opens in a new tab)